SafeStitch Medical, Inc. Announces Encouraging Result of Transluminal Procedure to Correct GERD and Obesity With Two Years Follow Up

Published: Jan 22, 2013

MIAMI--(BUSINESS WIRE)--SafeStitch MedicalĀ®, Inc. (OTCBB:SFES), SafeStitch Medical today reported positive findings in a seven patient preliminary pilot clinical trial using its proprietary transluminal devices to restrict gastric acid reflux in three patients and to cause meaningful weight reduction in two obese patients after two years.

Back to news